# STAR Cape+BKM120 MBC With Brain Met

> **NCT02000882** · PHASE2 · COMPLETED · sponsor: **US Oncology Research** · enrollment: 10 (actual)

## Conditions studied

- Brain Metastases
- Breast Cancer
- Metastatic Breast Cancer

## Interventions

- **DRUG:** BKM120
- **DRUG:** capecitabine
- **DRUG:** Trastuzumab

## Key facts

- **NCT ID:** NCT02000882
- **Lead sponsor:** US Oncology Research
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-05-29
- **Primary completion:** 2019-03-29
- **Final completion:** 2019-03-29
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2022-02-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02000882

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02000882, "STAR Cape+BKM120 MBC With Brain Met". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02000882. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*